Éric Lefebvre

9.5k total citations · 3 hit papers
137 papers, 6.2k citations indexed

About

Éric Lefebvre is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Éric Lefebvre has authored 137 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Infectious Diseases, 34 papers in Virology and 31 papers in Epidemiology. Recurrent topics in Éric Lefebvre's work include HIV/AIDS drug development and treatment (37 papers), HIV Research and Treatment (34 papers) and Laser-Plasma Interactions and Diagnostics (18 papers). Éric Lefebvre is often cited by papers focused on HIV/AIDS drug development and treatment (37 papers), HIV Research and Treatment (34 papers) and Laser-Plasma Interactions and Diagnostics (18 papers). Éric Lefebvre collaborates with scholars based in France, United States and Canada. Éric Lefebvre's co-authors include Tony Vangeneugden, V. Malka, Martine De Pauw, Sabrina Spinosa‐Guzman, Richard M. W. Hoetelmans, Sandra De Meyer, Vanitha Sekar, F. Burgy, A. Rousse and A. Pukhov and has published in prestigious journals such as The Lancet, Physical Review Letters and Circulation.

In The Last Decade

Éric Lefebvre

130 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Production of a keV X-Ray Beam from Synchrotron Radiation in Relativistic Laser-Plasma Interaction

2004 467 citations Éric Lefebvre, D. Umstadter et al. profile →
Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis

2017 421 citations Oliver Krenkel, Tobias Puengel et al. Hepatology profile →
Few femtosecond, few kiloampere electron bunch produced by a laser–plasma accelerator

2011 293 citations Éric Lefebvre et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Éric Lefebvre France	39	2.3k	1.9k	1.6k	1.3k	912	137	6.2k
Takashi Ishikawa Japan	44	225 0.1×	38 0.0×	1.0k 0.6×	649 0.5×	1.1k 1.2×	440	8.3k
Yuval Kluger United States	56	148 0.1×	55 0.0×	671 0.4×	774 0.6×	91 0.1×	155	12.4k
Jerrold S. Levine United States	43	175 0.1×	9 0.0×	552 0.4×	601 0.5×	211 0.2×	190	7.0k
R. L. White United States	52	187 0.1×	119 0.1×	102 0.1×	3.3k 2.6×	10 0.0×	290	12.1k
Haimin Wang United States	54	416 0.2×	85 0.0×	1.5k 0.9×	194 0.2×	1.1k 1.2×	370	11.5k
K. Nomoto Japan	74	106 0.0×	10 0.0×	340 0.2×	4.9k 4.0×	467 0.5×	467	19.8k
Raúl Rabadán United States	52	1.1k 0.5×	83 0.0×	1.8k 1.2×	401 0.3×	251 0.3×	201	12.5k
Michael T. Anderson United States	30	90 0.0×	125 0.1×	137 0.1×	339 0.3×	37 0.0×	86	3.8k
Hans G. Feichtinger Austria	45	123 0.1×	112 0.1×	504 0.3×	13 0.0×	39 0.0×	256	8.4k
Takashi Okamura Japan	37	160 0.1×	19 0.0×	399 0.3×	944 0.8×	96 0.1×	294	6.1k

Countries citing papers authored by Éric Lefebvre

Since Specialization

Citations

This map shows the geographic impact of Éric Lefebvre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Lefebvre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Lefebvre more than expected).

Fields of papers citing papers by Éric Lefebvre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Éric Lefebvre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Lefebvre. The network helps show where Éric Lefebvre may publish in the future.

Co-authorship network of co-authors of Éric Lefebvre

This figure shows the co-authorship network connecting the top 25 collaborators of Éric Lefebvre. A scholar is included among the top collaborators of Éric Lefebvre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Éric Lefebvre. Éric Lefebvre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Montesi, Sydney B., Gregory P. Cosgrove, Scott Turner, et al.. (2025). Dual αvβ6 and αvβ1 Inhibition over 12 Weeks Reduces Active Type I Collagen Deposition in Individuals with Idiopathic Pulmonary Fibrosis: A Phase 2, Double-Blind, Placebo-controlled Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 211(7). 1229–1240. 3 indexed citations

2.

Lancaster, Lisa, Vincent Cottin, Murali Ramaswamy, et al.. (2024). Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 210(4). 424–434. 35 indexed citations

3.

Daud, Adil, Chris N. Barnes, S. E. Owen, et al.. (2023). 714 Phase 1a trial of PLN-101095, an integrin αvβ8 and αvβ1 inhibitor, as monotherapy and in combination with pembrolizumab, in treatment-resistant patients with advanced or metastatic solid tumors. SHILAP Revista de lepidopterología. A809–A809. 1 indexed citations

4.

Nielsen, Mette Juul, Diana Julie Leeming, Zachary Goodman, et al.. (2021). Comparison of ADAPT, FIB-4 and APRI as non-invasive predictors of liver fibrosis and NASH within the CENTAUR screening population. Journal of Hepatology. 75(6). 1292–1300. 42 indexed citations

5.

Eksteen, Bertus, Christopher L. Bowlus, Aldo J. Montaño‐Loza, et al.. (2020). Efficacy and Safety of Cenicriviroc in Patients With Primary Sclerosing Cholangitis: PERSEUS Study. Hepatology Communications. 5(3). 478–490. 35 indexed citations

6.

Krenkel, Oliver, Tobias Puengel, Olivier Govaere, et al.. (2017). Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis. Hepatology. 67(4). 1270–1283. 421 indexed citations breakdown →

7.

Kagan, Ron M., Erik P. Johnson, M F Siaw, et al.. (2013). Comparison of Genotypic and Phenotypic HIV Type 1 Tropism Assay: Results from the Screening Samples of Cenicriviroc Study 202, a Randomized Phase II Trial in Treatment-Naive Subjects. AIDS Research and Human Retroviruses. 30(2). 151–159. 12 indexed citations

8.

Powers, Nathan, Isaac Ghebregziabher, C. M. Maharjan, et al.. (2012). ブロウアウト領域におけるレーザ航跡場加速器からの波長可変、100-800MeV準単色電子ビームの発生. Physics of Plasmas. 19(5). 56703–56703. 1 indexed citations

9.

Rodríguez, Sabrina, et al.. (2008). Dinámica de la excreción natural del Virus de la Leucosis Bovina en semen de toros infectados naturalmente. Open Repository and Bibliography (University of Liège).

10.

Meyer, Sandra De, Tony Vangeneugden, Ben Van Baelen, et al.. (2008). Resistance Profile of Darunavir: Combined 24-Week Results from the POWER Trials. AIDS Research and Human Retroviruses. 24(3). 379–388. 121 indexed citations

11.

Sekar, Vanitha, et al.. (2007). Pharmacokinetic Interaction Between Darunavir and Saquinavir in HIV-negative Volunteers. Therapeutic Drug Monitoring. 29(6). 795–801. 17 indexed citations

12.

Hoy, Jennifer, et al.. (2006). Body mass change and anthropometric-related adverse events at week 24 in treatment-experienced HIV-infected patients receiving TMC114/r or control PIs in POWER 1, 2 and 3. Antiviral Therapy. 11(7). 1 indexed citations

13.

Michalska, H., et al.. (2005). Track-Before Detect Methods in Tracking Low-Observable Targets: A Survey. SHILAP Revista de lepidopterología. 19 indexed citations

14.

Alter, Galit, George Hatzakis, Christos Tsoukas, et al.. (2003). Longitudinal Assessment of Changes in HIV-Specific Effector Activity in HIV-Infected Patients Starting Highly Active Antiretroviral Therapy in Primary Infection. The Journal of Immunology. 171(1). 477–488. 41 indexed citations

15.

Lefebvre, Éric, et al.. (2002). The EPICA borehole logger. Memoirs of National Institute of Polar Research. Special issue. 56. 264–274. 3 indexed citations

16.

Routy, Jean‐Pierre, Philippe Vanhems, Danielle Rouleau, et al.. (2000). Comparison of Clinical Features of Acute HIV-1 Infection in Patients Infected Sexually or Through Injection Drug Use. JAIDS Journal of Acquired Immune Deficiency Syndromes. 24(5). 425–432. 23 indexed citations

17.

Routy, Jean‐Pierre, Philippe Vanhems, Danielle Rouleau, et al.. (2000). Comparison of Clinical Features of Acute HIV-1 Infection in Patients Infected Sexually or Through Injection Drug Use. JAIDS Journal of Acquired Immune Deficiency Syndromes. 24(5). 425–432. 16 indexed citations

18.

Coad, Peter, et al.. (1999). Java modeling in color with UML: enterprise components and process. Prentice Hall PTR eBooks. 82 indexed citations

19.

Coad, Peter, et al.. (1999). Java Modeling Color with Uml: Enterprise Components and Process with Cdrom. Prentice Hall PTR eBooks. 33 indexed citations

20.

Berland, J, et al.. (1972). [Percutaneous valvotomy in the combination of mitral and tricuspid valve stenosis. Report of 3 cases].. Medical Entomology and Zoology. 18(10). 107–118. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact